Dec 27, 2021 05:43AM
Dec 25, 2021 08:00AM
Dec 9, 2021 08:41AM
Nov 18, 2021 07:01AM
Nov 18, 2021 07:00AM
Nov 9, 2021 07:30AM
Nov 4, 2021 01:15PM  Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021
Oct 19, 2021 07:33AM
Oct 19, 2021 07:30AM
Oct 15, 2021 04:01PM
Sep 28, 2021 07:31AM
Sep 28, 2021 07:30AM
Sep 22, 2021 07:30AM
Aug 9, 2021 07:00AM Dicerna Announces Second Quarter 2021 Financial Results and Provides a Business Update
Aug 6, 2021 09:22AM
Aug 5, 2021 04:03PM
Aug 5, 2021 04:01PM
Jul 29, 2021 07:47AM
Jul 29, 2021 07:30AM
Jun 16, 2021 07:30AM
May 27, 2021 07:32AM Dicerna Pharma (DRNA) Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for LY3819469
May 27, 2021 07:30AM
May 6, 2021 04:05PM
Apr 8, 2021 07:40AM
Apr 8, 2021 07:40AM
Apr 8, 2021 07:38AM
Apr 8, 2021 07:30AM
Feb 25, 2021 04:05PM Dicerna Announces Full Year 2020 Financial Results and Provides a Business Update
Feb 11, 2021 07:50AM
Feb 11, 2021 07:30AM
Jan 5, 2021 04:05PM
Jan 4, 2021 07:30AM
Nov 16, 2020 07:32AM
Nov 16, 2020 07:30AM
Oct 22, 2020 10:06AM Dicerna (DRNA) Presents Positive New Interim Data From PHYOX3 Long-Term, Open-Label Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria
Oct 22, 2020 10:05AM
Aug 6, 2020 07:00AM
Jun 18, 2020 07:33AM
Jun 18, 2020 07:30AM
May 7, 2020 04:05PM
Apr 6, 2020 07:03AM
Apr 6, 2020 07:00AM Alnylam and Dicerna Form RNAi Therapeutics Collaboration on Alpha-1 Antitrypsin Deficiency-Associated Liver Disease and Complete Cross-License Agreement for Primary Hyperoxaluria Programs
Mar 26, 2020 04:23PM
Mar 26, 2020 04:05PM
Mar 19, 2020 09:25AM
Mar 18, 2020 05:55PM
Mar 18, 2020 04:07PM
Mar 18, 2020 04:05PM
Nov 7, 2019 04:05PM Dicerna™ Announces Third Quarter 2019 Financial Results and Reports Development Programs Progress
Oct 31, 2019 09:06AM

322,094 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All